BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19404521)

  • 1. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ; Janssen G; Borkhardt A
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent immune thrombocytopenic purpura in children.
    Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
    Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
    Van Riet FA; Wessels G; Hesseling PB
    East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
    Dickerhoff R; von Ruecker A
    J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ; Buchanan GR
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
    Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
    Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG
    Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.